An Open-Label Study To Assess The Long-Term Safety And Efficacy Of An Investigational Medications In Patients With Major Depression
Posted Date: Jul 23, 2019
- Investigator: Lesley Arnold
- Specialties: Depression, Psychiatry/Psychology
- Type of Study: Drug
The goal of this study is to evaluate the long-term safety and efficacy of an investigational medication in people with major depression. The study is open-label, which means that all participants will receive the medication for up to 12 months.
Male Or Female Individuals, Age 18 To 65, With Major Depression Who Have Completed A Previous Study Of The Investigational Medication.
Depression, Major Depression
For More Information: